Atypical Anti-psychotics (long-acting injectable) - Index
Medications listed in the tables and non-FDA approved indications included in these retrospective criteria are not indicative of Texas Vendor Drug Program formulary coverage.
- Revision history
- Oct. 13, 2023
- Oct. 22, 2021
- Sept. 2019
- Initially developed
- Sept. 2017